No licensed vaccine exists yet for cytomegalovirus.

Researchers combined immune-database screening with structural modeling to assemble a multi-epitope candidate that binds two key innate-immunity receptors.

Simulations predict a strong antibody response, but the design still needs experimental and clinical validation.

Sources: Nature